Resonium Calcium pulver til oral suspension/rektalvæske, suspension Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

resonium calcium pulver til oral suspension/rektalvæske, suspension

paranova danmark a/s - calciumpolystyrensulfonat - pulver til oral suspension/rektalvæske, suspension

Resonium-Calcium pulver til oral suspension/rektalvæske, suspension Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

resonium-calcium pulver til oral suspension/rektalvæske, suspension

orifarm a/s - calciumpolystyrensulfonat - pulver til oral suspension/rektalvæske, suspension

Bimzelx Evrópusambandið - danska - EMA (European Medicines Agency)

bimzelx

ucb pharma s.a.   - bimekizumab - psoriasis - immunosuppressiva - plaque psoriasisbimzelx is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisbimzelx, alone or in combination with methotrexate, is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)bimzelx is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri) who have responded inadequately or are intolerant to non-steroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)bimzelx is indicated for the treatment of adults with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy.

Tezspire Evrópusambandið - danska - EMA (European Medicines Agency)

tezspire

astrazeneca ab - tezepelumab - astma - medicin for obstruktiv sygdomme, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.